{"database": "lobbying", "table": "lobbying_activities", "rows": [[1917689, "c4c15172-b7d0-40fa-ac0e-b38bcde924a3", "4T", "WALTER CONSULTING", 301697, "AMERISOURCEBERGEN CORPORATION", 2016, "fourth_quarter", "PHA", "H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015\nS.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 1, "2017-01-18T12:46:00-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1917689"], "units": {}, "query_ms": 20.664350944571197, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}